$TTOO T2 Biosystems, Inc. Insider Trading
Get free email notifications about insider trading in T2 Biosystems, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in T2 Biosystems, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in T2 Biosystems, Inc. for free.
IRS Number: 204827488
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: TTOO
Company Address: 101 HARTWELL AVENUE LEXINGTON 02421
Phone number: 781-457-1200
Former name: Bioplex Systems, Inc.
T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
Market Capitalization: $170.72M
Prev close: $5.64
Average Daily Volume: 87,476
Days Low: $5.50
Year Low: $4.89
Year High: $11.30
T2 Biosystems, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Sell | S | 1.86 | 12,494 | 23,239 | 74,420 | 86.9 K to 74.4 K (-14.38 %) |
| Mar 18 2021 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Sell | S | 1.84 | 9,620 | 17,701 | 31,612 | 41.2 K to 31.6 K (-23.33 %) |
| Mar 16 2021 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Option Exercise | M | 0.00 | 17,500 | 0 | 35,000 | |
| Mar 16 2021 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Buy | M | 0.00 | 17,500 | 0 | 41,232 | 23.7 K to 41.2 K (+73.74 %) |
| Mar 16 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Option Exercise | M | 0.00 | 21,667 | 0 | 43,333 | |
| Mar 16 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Buy | M | 0.00 | 21,667 | 0 | 86,914 | 65.2 K to 86.9 K (+33.21 %) |
| Feb 26 2021 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Option Exercise | A | 0.00 | 505,464 | 0 | 505,464 | |
| Feb 26 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Option Exercise | A | 0.00 | 505,464 | 0 | 505,464 | |
| Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Sell | S | 2.06 | 7,280 | 14,997 | 65,347 | 72.6 K to 65.3 K (-10.02 %) |
| Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Buy | M | 0.00 | 10,000 | 0 | 72,627 | 62.6 K to 72.6 K (+15.97 %) |
| Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Sell | S | 2.04 | 5,250 | 10,710 | 35,485 | 40.7 K to 35.5 K (-12.89 %) |
| Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Buy | M | 0.00 | 10,000 | 0 | 40,735 | 30.7 K to 40.7 K (+32.54 %) |
| Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 |